Goat Infant Formula Feeding and Eczema (the GIraFFE Study)

Prior treatment

• Infant has a doctor's diagnosis of atopic dermatitis or a severe widespread skin condition prior to randomization that would make the detection or assessment of atopic dermatitis difficult
• Infant has consumed an infant formula for more than 4 weeks prior to enrolment

Other illness

• Diagnosed disorder considered to interfere with nutrition, growth or development of the immune system
• Cow milk allergy or intolerance

Other

• Participation of the child in any other interventional trial or participation of the mother in any intervention trial with child follow-up
• Institutionalized infant

• Having obtained written informed consent (signed and dated) of the child's parent(s)/caregiver(s), indicating that the child's parent(s)/caregiver(s) has/have been informed of all pertinent aspects of the study
• Born full term (≥37 weeks +0 days and ≤ 41 weeks +6 days of gestation)
• Age at enrolment \< 3 months of age (\<90 days)
• Birth weight ≥2.5 kg and ≤4.5 kg
• Born from a singleton pregnancy
• Child's parent(s)/caregiver(s) is/are of legal age of consent
• The child's parent(s)/caregiver(s) have sufficient local language skills to understand the study information, the informed consent, and to comply with the study procedure
• The child's parent(s)/caregiver(s) is/are willing and deemed able to fulfil the requirements of the study protocol and procedures
• Mother has expressed the intention to partially (in combination with breastfeeding) or fully formula-feed